How Merck extended its monopoly on a blockbuster diabetes drug columbian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from columbian.com Daily Mail and Mail on Sunday newspapers.
How Merck extended its monopoly on a blockbuster diabetes drug fresnobee.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fresnobee.com Daily Mail and Mail on Sunday newspapers.
Merck's diabetes drug highlights debate over U.S. patent system inquirer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inquirer.com Daily Mail and Mail on Sunday newspapers.
Reverse payment cases arise in the context of settlement agreements between brand-name pharmaceutical companies and generic drug manufacturers to resolve patent litigation under the Hatch-Waxman Act.
The Supreme Court's consideration of the standards for satisfying the enablement provisions of 35 U.S.C. 112(a) has been occasioned for the first time in over a century by the Court's.